GSK plc (GSK)

GSK develops vaccines, specialty medicines, and consumer healthcare products distributed in numerous countries. Its vaccine portfolio covers prevention of shingles, respiratory syncytial virus, meningitis, and influenza, while pharmaceutical products target respiratory, oncology, and infectious disease areas. Healthcare systems and patients use these products for immunization and treatment of common and serious conditions.

Market
NYSE
Sector
Healthcare
Trend
Downtrend
Last close
49.89 (-1.93% on the day)
MA50
51.34
MA200
51.44
52-week range
38.17–59.6
Market cap
100.6B USD
P/E
15.7
Dividend yield
1.34%
Data as of
2026-09-04
Quarterly revenue and earnings, millions of GBP
QuarterRevenueYoY %EarningsYoY %
Q2 20257,9861,443
Q3 20258,5472,013
Q4 20258,618636
Q1 20267,6291,737
Q2 20268,4095.3%435-69.8%

All markets — KeepWinning global stock screener

Other companies on NYSE: General Dynamics Corporation (GD), Vertiv Holdings Co (VRT), Phillips 66 (PSX), Trane Technologies plc (TT), Howmet Aerospace Inc. (HWM), ASE Technology Holding Co., Ltd. (ASX)